Patents by Inventor Walter Rene Antonius Van Heumen

Walter Rene Antonius Van Heumen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified Cpn10 and PRR signalling
    Patent number: 9234019
    Abstract: The present invention relates to isolated Cpn10 polypeptides possessing an increased affinity for a PRR ligand compared to Ala Cpn10 polypeptide. In a further embodiment, the present invention also relates to modified chaperonin 10 polypeptides, and to nucleic acids encoding the same and to compositions comprising such polypeptides and uses thereof.
    Type: Grant
    Filed: April 9, 2009
    Date of Patent: January 12, 2016
    Assignee: CBio Limited
    Inventors: Dean Jason Naylor, Richard James Brown, Christopher Bruce Howard, Christopher John De Bakker, Linda Alisson Ward, Jeanette Elizabeth Stok, Andrew Leigh James, Daniel Scott Lambert, Kylie Jane Ralston, Walter Rene Antonius Van Heumen
  • CHAPERONIN 10 VARIANTS
    Publication number: 20150274794
    Abstract: The invention relates generally to chaperonin 10 N-terminal variants. More specifically, the invention relates to chaperonin 10 N-terminal variants with enhanced immunomodulatory capacity and/or enhanced binding affinity for pathogen-associated molecular patterns (PAMPs) and/or damage-associated molecular patterns (PAMPs).
    Type: Application
    Filed: January 13, 2015
    Publication date: October 1, 2015
    Inventors: Dean Jason NAYLOR, Richard James BROWN, Christopher Bruce HOWARD, Christopher John DE BAKKER, Jeanette Elizabeth STOK, Andrew Leigh JAMES, Daniel Scott LAMBERT, Kylie Jane RALSTON, Walter Rene Antonius VAN HEUMEN, Linda Allison WARD
  • Chaperonin 10 variants
    Patent number: 8933033
    Abstract: The invention relates generally to chaperonin 10 N-terminal variants. More specifically, the invention relates to chaperonin 10 N-terminal variants with enhanced immunomodulatory capacity and/or enhanced binding affinity for pathogen-associated molecular patterns (PAMPs) and/or damage-associated molecular patterns (DAMPs).
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: January 13, 2015
    Assignee: CBio Limited
    Inventors: Dean Jason Naylor, Richard James Brown, Christopher Bruce Howard, Christopher John De Bakker, Jeanette Elizabeth Stok, Andrew Leigh James, Daniel Scott Lambert, Kylie Jane Ralston, Walter Rene Antonius Van Heumen, Linda Allison Ward
  • CHAPERONIN 10 VARIANTS
    Publication number: 20120328635
    Abstract: The invention relates generally to chaperonin 10 N-terminal variants. More specifically, the invention relates to chaperonin 10 N-terminal variants with enhanced immunomodulatory capacity and/or enhanced binding affinity for pathogen-associated molecular patterns (PAMPs) and/or damage-associated molecular patterns (DAMPs).
    Type: Application
    Filed: October 8, 2010
    Publication date: December 27, 2012
    Applicant: CBio Limited
    Inventors: Dean Jason Naylor, Richard James Brown, Christopher Bruce Howard, Christopher John De Bakker, Jeanette Elizabeth Stok, Andrew Leigh James, Daniel Scott Lambert, Kylie Jane Ralston, Walter Rene Antonius Van Heumen, Linda Allison Ward
  • PREVENTION AND TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOSUS
    Publication number: 20110243921
    Abstract: Disclosed herein, in certain embodiments, are methods and compositions for the prevention and treatment of autoimmune disease. Further disclosed herein, in certain embodiments, are methods for the prevention and treatment of cutaneous lupus erythematosus. Additionally disclosed herein, in certain embodiments, are compositions for the prevention and treatment of cutaneous lupus erythematosus.
    Type: Application
    Filed: March 30, 2010
    Publication date: October 6, 2011
    Applicant: CBIO LIMITED
    Inventors: Hans-Joachim Anders, Dean Jason Naylor, Richard James Brown, Walter Rene Antonius Van Heumen
  • Modified Cpn10 and PRR signalling
    Publication number: 20110082073
    Abstract: The present invention relates to isolated Cpn10 polypeptides possessing an increased affinity for a PRR ligand compared to Ala Cpn10 polypeptide. In a further embodiment, the present invention also relates to modified chaperonin 10 polypeptides, and to nucleic acids encoding the same and to compositions comprising such polypeptides and uses thereof.
    Type: Application
    Filed: April 9, 2009
    Publication date: April 7, 2011
    Applicant: CBIO LIMITED
    Inventors: Dean Jason Naylor, Richard James Brown, Christopher Bruce Howard, Christopher John De Bakker, Linda Alisson Ward, Jeanette Elizabeth Stok, Andrew Leigh James, Daniel Scott Lambert, Kylie Jane Ralston, Walter Rene Antonius Van Heumen